Stock Analysis·← Pickers

MDAI

Spectral AI, Inc.

Spectral AI, Inc. (MDAI) is currently in a range/mixed trend, trading below both the 50-day and 200-day moving averages. RSI is at 40.3, with 1/3 trend checks passing.

Price
$1.69
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
40.3
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

MDAI with MA50 and MA200

2.682.311.941.571.2007/3110/2401/2204/1707/15
MDAI2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.99-15.12% vs price
MA200
$1.79-5.68% vs price
RSI (14)
40.3Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for MDAI

Spectral AI, Inc. (MDAI) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $1.69, and 1 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 15.1% and below the 200-day moving average by 5.7%.

Momentum and stretch context

MDAI currently has an RSI reading of 40.3, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

This page is designed to help you quickly understand what the MDAI chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Spectral AI, Inc.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.

Sector
Healthcare
Industry
Medical - Specialties
CEO
Vincent S. Capone
Employees
65
Market cap
$53.8M
Beta
1.17
52-week range
$1.18 – $2.97
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
6 Apr 2021
ISIN
US84757T1051
CUSIP
84757T105
Company profile data from Financial Modeling Prep. MDAI listed on NASDAQ.
Share dilution

MDAI shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Sept 2021Mar 2026
Shares outstanding (latest)
31.8M
Since Sept 2021
+402.1%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. MDAI19 data points from Sept 2021 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about MDAI

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.